Clinical Case Reports · 2020 · 14 citations · 19 references
MedicineEndocrinologyOncologyCutaneous OncologyEndocrine OncologyMetastasisAndrogen TherapyEndocrine Surgical OncologyEndocrine Tumor PathologyEndocrine TumorsHormonal Cancer TherapyProstate CancerAndrogen Receptor ExpressionApocrine GlandsCutaneous Metastatic TumorsEndocrine MetastasesEndocrine Tumor MetastasisMetastatic Endocrine TumorsSweat Gland TumorsSystemic Hormone Therapy
Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti-androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.
19
Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Hervé Bonnefoi, Thomas Grellety, Olivier Trédan et al. · Annals of Oncology · 2016 · 281 citations · Full text
Medicine, Oncology, Pharmacology +17
Primary Cutaneous Apocrine Carcinoma
Alistair Robson, Alexander J. Lazar, Jara Ben Nagi et al. · The American Journal of Surgical Pathology · 2008 · 152 citations
Medicine, Dermatology, Oncology +12